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Abstract Tianeptine (Tian) possesses neuroprotective
potential, however, little is known about the effect of this
drug in models of neuronal apoptosis. In the present study,
we aimed (1) to compare the neuroprotective capacities of
some antidepressants (ADs) in the models of staurosporine
(St)- and doxorubicin (Dox)-evoked cell death, activating
the intracellular and the extracellular apoptotic pathway,
respectively; (2) to identify the Tian-modulated steps
underlying its neuroprotective action; (3) to test the effect
of various ADs against Dox-evoked cell damage in glia
cells. Primary neuronal and glia cell cultures and retinoic
acid-differentiated human neuroblastoma SH-SY5Y (RA-
SH-SY5Y) cells were co-treated with imipramine, fluoxe-
tine, citalopram, reboxetine, mirtazapine or Tian and St or
Dox. The data showed the predominant neuroprotective
effect of Tian over other tested ADs against St- and Dox-
induced cell damage in primary neurons and in RA-SH-
SY5Y cells. This effect was shown to be caspase-3-inde-
pendent but connected with attenuation of DNA fragmen-
tation. Moreover, neuroprotection elicited by Tian was
blocked by pharmacological inhibitors of MAPK/ERK1/2
and PI3-K/Akt signaling pathways as well by inhibitor of
necroptosis, necrostatin-1. Interestingly, the protective
effects of all tested ADs were demonstrated in primary glia
cells against the Dox-evoked cell damage. The obtained
data suggests the glial cells as a common target for
protective action of various ADs whereas in relation to
neuronal cells only Tian possesses such properties, at least
against St- and Dox-induced cell damage. Moreover, this
neuroprotective effect of Tian is caspase-3-independent
and engages the regulation of survival pathways (MAPK/
ERK1/2 and PI3-K/Akt).
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to the group of atypical antidepressants (ADs) with a
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unique mechanism of action which is still not fully
understood (McEwen and Olie 2005; McEwen et al. 2010).
However, in contrast to other ADs, tianeptine (Tian) has
been reported to increase neuronal serotonin (5-HT) reup-
take, but this phenomenon is rather not responsible for the
clinical efficacy of this drug (Fattaccini et al. 1990; McE-
wen et al. 2010; Mennini et al. 1987). In fact, more specific
studies clearly showed that acute and long-term adminis-
tration of Tian did not elicit any marked alterations in
extracellular 5-HT levels in corticolimbic structures of
conscious rats (Malagie et al. 2000; Pineyro et al. 1995). It
is well documented that Tian mediates the AD effect via
the regulation of HPA axis and normalization of the
glutamatergic system (McEwen et al. 2010). The latter is
connected with the ability of Tian to modulate (1) gluta-
mate transmission via induction of serine phosphorylation
at AMPA receptors which positively regulates glutamate
transmission and plasticity at excitatory synapses (Kole
et al. 2002; Qi et al. 2009; Svenningsson et al. 2007;
Szegedi et al. 2011; Zhang et al. 2012b) and (2) glutamate
turnover as demonstrated by the inhibiting effect of Tian on
chronic restraint stress-induced changes in glutamate
transporter EAAT2 (GLT1) expression on glial cells
(Reagan et al. 2004) and stimulating properties on gluta-
mate efflux and vGLUT2 expression in central amygdalar
complex of rats subjected to repeated stress (Piroli et al.
2013).
Many experimental studies and clinical observations
underline the engagement of degenerative processes of
neuronal and glia cells in the pathomechanism of depres-
sion (Catena-Dell’Osso et al. 2013; Cobb et al. 2013; Fuchs
et al. 2004; McKernan et al. 2009; Rajkowska 2002; Ra-
jkowska and Miguel-Hidalgo 2007). On the other hand,
clinically used AD drugs exhibited neuroprotective prop-
erties in various in vitro and in vivo models of neuronal
injury although usually chronic treatment was required to
achieve beneficial effects (Drzyzga et al. 2009; McEwen
et al. 2010; McKernan et al. 2009). Regarding the neuro-
protective action of Tian, this drug has been shown to
possess anti-apoptotic action after chronic treatment
(50 mg/kg p.o., 28 days) in the psychosocial stress model
in tree shrews (Lucassen et al. 2004) as well prevented the
morphological changes in the brain of chronically stressed
rats (Della et al. 2012a). Other reports provided data on the
neuroprotective action of Tian in in vitro (NMDA,
hypoxia) and in vivo (ibotenic acid) models of excitotox-
icity, although only when the cell-damaging agents were
combined with interleukin-1b treatment. The beneficial
effect of Tian in the above models was explained by anti-
inflammatory properties of this drug (Plaisant et al. 2003),
which was also confirmed by a normalizing effect of
Tian on production of pro- and anti-inflammatory cyto-
kines after lipopolysaccharide (LPS) treatment in rat
hypothalamus (Castanon et al. 2004). Recently, it has been
shown that Tian affords protection not only to neurons but
also to glia cells. Studies performed on astroglial cell lines
demonstrated the attenuating effect of Tian (C10 lM) on
apoptosis induced by glycoprotein 120 (gp120) (Janda
et al. 2011).
It should be underlined that in most studies on neuro-
protective potential of various class of ADs, only one or a
few of them were tested in parallel in one study. However,
it seems that for reliable comparison of neuroprotective
effectiveness of various ADs, the drugs should be tested
parallelly under the same experimental settings. Secondly,
there is still an open question of how far the protection
mediated by various ADs (including also Tian) is neuron-
specific or whether it engages also other cells (e.g., glia
cells). Regarding the neuroprotective capacities of Tian,
there is still a lack of data on the effects of this drug in
models of neuronal injury not directly connected with
glutamate overactivation (excitotoxicity), especially in
models of apoptosis. In the present study, we aimed to test
the effect of various ADs belonging to different pharma-
cological classes [tricyclic AD drug-imipramine (Imi),
selective serotonin reuptake inhibitors (SSRIs): fluoxetine
(Flu) and citalopram (Cit), selective noradrenaline reuptake
inhibitor—reboxetine (Reb) and atypical ADs—mirtaza-
pine (Mirt) and Tian]. It should be mentioned here that
apart from the modulation of the monoaminergic system,
chronic ADs treatment has been shown to selectively
increase expression of neurotrophins (BDNF) and plastic-
ity-related proteins (PSA-NCAM, pCREB, GAD-43) in the
hippocampus and prefrontal cortex of the rat (McKernan
et al. 2009).
In the present study, we tested the chosen ADs in a wide
concentration range (0.001–10 lM) in two typical models
of cellular apoptosis. We used two chemical agents for
induction of mitochondrial (staurosporine, St) and extra-
cellular (doxorubicin, Dox) apoptotic pathway in mouse
primary cortical neurons and in retinoic acid-differentiated
human neuroblastoma SH-SY5Y (RA-SH-SY5Y) cells.
We also tested the effect of ADs on cell death induced by
Dox in mouse primary glia cells. The results may provide
further information on which ADs exert the best neuro-
protective effect in models of neuronal apoptosis directly
unrelated to the glutamatergic overactivation (Jantas et al.
2009; Jantas and Lason 2009).
Methods
Reagents and Antibodies
Antidepressant drugs: imipramine hydrochloride (Sigma-
Aldrich Chemie GmbH, Germany), fluoxetine hydrochloride
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(Farmacom, Poland), citalopram (Lundbeck, Denmark),
reboxetine (Pharmacia, Italy), mirtazapine (Organon, The
Netherlands), tianeptine sodium (Servier, France).
Neurobasal A medium, Dulbecco’s modified Eagle’s
medium (DMEM), fetal bovine serum (FBS), supplement
B27 were from Gibco (Invitrogen, Paisley, UK). The
Cytotoxicity Detection Kit, BM Chemiluminescence
Western Blotting Kit and In Situ Cell Death Detection Kit
Fluorescein were from Roche Diagnostic (Mannheim,
Germany). Primary antibodies: anti-MAP-2 (sc-51669),
antiphospho-Tyr204 ERK 1/2 (pERK, sc-7383), anti-ERK2
(sc-474), anti-spectrin a IIsc-48382), protein markers and
appropriate secondary antibodies were from Santa Cruz
Biotechnology Inc. (CA, USA). All other reagents were
from Sigma (Sigma-Aldrich Chemie GmbH, Germany).
Neuronal Cell Cultures
The experiments were conducted on primary cultures of
mouse cortical neurons and on neuronal differentiated
human neuroblastoma SH-SY5Y cells as described previ-
ously (Jantas et al. 2008; Jantas-Skotniczna et al. 2006).
The protocol for generation of the primary neuronal cul-
tures was concordant with local and international guidelines
on the ethical use of animals. Neuronal tissues were taken
from Swiss mouse embryos at 15/16th day of gestation and
were cultured essentially as described previously (Jantas-
Skotniczna et al. 2006). The isolated cortical cells were
suspended in Neurobasal medium containing penicillin
(0.06 lg/ml) and streptomycin (0.1 lg/ml), supplement B27
without antioxidants and were plated at a density of
1.5 9 105 cells/cm2 onto poly-ornithine (0.05 mg/ml)-
coated multi-well plates. This procedure typically yields
cultures that contain[90 % neurons and\10 % supporting
cells as verified by immuncytochemistry (not shown). The
cultures were then maintained at 37 C in a saturated
humidity atmosphere containing 95 % air and 5 % CO2 for
7 days prior to experimentation and culture medium was
exchanged every 2 days.
The human SH-SY5Y neuroblastoma cells (ATCC),
passages 5–20 were grown in DMEM supplemented with
10 % heat-inactivated FBS and 100 units/ml of penicillin
and 100 lg/ml of streptomycin as described previously
(Jantas et al. 2008). Cells were maintained at 37 C in a
saturated humidity atmosphere containing 95 % air and
5 % CO2. After reaching an 80 % confluence, cells were
seeded onto appropriate multi-well plates at a density of
4 9 104 cells/cm2 and were differentiated to a neuronal
phenotype for 7 days by adding retinoic acid (RA) to the
culture medium at a final concentration of 10 lM. The
culture medium with RA was changed three times during
the period of differentiation. One day before the experi-
mental treatment of RA-differentiated SH-SY5Y cells, the
culture medium was replaced by DMEM containing anti-
biotics and 1 % FBS.
Glia Cell Cultures
Cortical glia cells were prepared from 2-day-old Albino
Swiss mice according to the protocol described by Johann
et al. (2008) with some modifications. Briefly, cerebral
cortices were dissected, meninges were removed and tissues
were minced separately into small pieces, then digested
with trypsin (0.1 % for 30 min at 37 C), triturated in the
presence of 20 % fetal bovine serum and DNAse I
(150 Kunitz units/ml), and finally centrifuged for 5 min at
1009g. Cells were resuspended in DMEM containing 20 %
FBS and 100 units/ml of penicillin and 100 lg/ml of
streptomycin. Finally, cells were seeded into 75-cm2 culture
bottles coated with poly-ornithine (0.05 mg/ml) and grown
at 37 C in a humidified incubator with 5 % CO2. Culture
medium initially contained 20 % of FBS and after 4 days
was replaced with medium containing 10 % FBS and was
exchanged twice a week. Cells after reaching about
80–90 % confluence were trypsinized and replated at a
lower density. This procedure was repeated three times and
after the last trypsinization cells were seeded on poly-
ornithine-coated 96-well plates. Four- week-old glia cell
cultures were used for drug testing. Three days before drug
exposure culture medium was replaced with the culture
medium used for cortical neurons (Neurobasal medium,
antibiotics, and B27 supplement) in order to reduce cell
proliferation and to achieve similar experimental conditions
for drug treatment as in primary neurons. One day before
the cell treatment, Neurobasal culture medium was replaced
with fresh one. The obtained glia cultures are characterized
by about 90 % homogeneity of glial fibrillary acidic protein
(GFAP)-positive cells with no neuronal (MAP-2-positive
cells) contamination (not shown).
Immunocytochemistry
The purity of primary neuronal and glia cultures and the
morphological changes in cortical neurons after a particular
drug treatment were determined by immunocytochemistry
as described by Singh et al. (2010). At particular DIV (7th
for neuronal and 4 weeks for glia cells) cells were washed
with pre-warmed phosphate-buffered saline (PBS), fixed
for 20 min at RT with 4 % paraformaldehyde and washed
twice with PBS. Next the cells were permeabilized with
PBS-containing 0.25 % Triton X-100 (PBS-TX-100) for
15 min after which the blocking was performed in the
presence of 5 % normal goat serum in PBS-TX-100 at
room temperature for 60 min. Primary antibodies against
neuronal (anti-MAP-2, 1:250) and glia (anti-GFAP, 1:500)
markers were added and incubated with cells for the next
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60 min at RT. Subsequently, cells were washed three times
with PBS and incubated for 60 min at RT in the presence
of secondary antibodies: Alexa Fluor488 labeled goat
anti-mouse and Alexa Fluor568 labeled goat anti-rabbit
IgG (Invitrogen, USA) diluted 1:500 in PBS. Cells were
washed with PBS three times for 5 min and mounted with
ProLongGold antifade reagent (Invitrogen, USA). Cells
were examined using a fluorescence AxioObserver micro-
scope (Carl Zeiss, Germany) equipped with the software
Axiovision 3.1 at excitation wavelengths of 470 nm (Alexa
Fluor488) and 555 (Alexa Fluor568).
Cell Treatment
Seven days in vitro (DIV) cortical neurons were co-treated
with Tian (0.001–10 lM) and St (0.5 lM) or Dox (0.5 lM)
for 14–48 h. RA-SH-SY5Y cells were incubated with Tian
(0.01–10 lM) and St (0.5 lM) or Dox (1 lM) for 14–48 h.
The effective concentrations and time of exposure to St and
Dox were chosen on the basis of our previous reports where
these pro-apoptotic factors evoked about 50 % reduction in
cell viability of cortical neurons and RA-SH-SY5Y cells
(Jantas et al. 2008, 2009; Jantas and Lason 2009; Jantas-
Skotniczna et al. 2006). For comparative studies between
the effects of Tian with other ADs, cortical neurons and RA-
SH-SY5Y cells were co-treated with Imi, Flu, Cit, Reb, or
Mirt at concentrations from 0.01 to 10 lM and St or Dox. In
glia cell cultures, we also tested the protective effect of Tian
and other ADs (Imi, Flu, Cit, Reb, Mirt) at concentrations
0.01–10 lM against cell damage induced by Dox (1 lM for
48 h). An involvement of PI-3 K/Akt and MAPK/ERK/1/2
pathways as well as necroptosis in Tian-mediated neuro-
protection was tested by using specific inhibitors of these
pathways: LY294002 (10 lM), U0126 (10 lM) and ne-
crostatin-1 (10 lM) which were added 30 min before
treatment of neuronal cells with Tian and St or Dox. The
caspase-3 inhibitor (Ac-DEVD-CHO, 10 lM) was added to
cells 20 min before treatment of cells with St or Dox. St
(1 mM), Ac-DEVD-CHO (10 mM), LY 294002 (10 mM),
necrostatin-1 (100 mM), and U0126 (10 mM) stock solu-
tions were prepared in dimethyl sulfoxide. Mirt stock
solution (10 mM) was prepared in distilled water acidified
with few drops of 0.1 M HCl followed by pH adjustment to
7.15 with 0.1 M NaOH. Dox, Imi, Flu, Cit, Reb, and Tian
were dissolved in distilled water. The chemicals were
present in cultures at a final concentration of 0.1 % and
vehicle-treated cells were treated with a relevant solvent.
Measurement of Lactate Dehydrogenase (LDH)
Release
In order to estimate cell death, the level of lactate dehy-
drogenase (LDH) released from damaged cells into culture
media was measured after 24 and 48 h of treatment of cells
with ADs and St or Dox, respectively, as described pre-
viously (Jantas-Skotniczna et al. 2006). Cell-free culture
supernatants were collected from each well and incubated
with the appropriate reagent mixture according to the
supplier’s instructions (Cytotoxicity Detection Kit, Roche)
at RT for 20 min. The intensity of red color formed in the
assay and measured at a wavelength of 490 nm was pro-
portional to LDH activity and to the number of damaged
cells. Absorbance of blanks, determined as no-enzyme
control, has been subtracted from each value. The data
were normalized to the activity of LDH released from
vehicle-treated cells (cortical neurons and glia cells) or
toxin-treated cells (RA-SH-SY5Y cells) and expressed as a
percent of the control ± SEM or a percent of toxin-indu-
ced ± SEM established from n = 5 wells per one experi-
ment from three separate experiments.
MTT Reduction Assay
Cell viability assessment was done after 24–48 h of treat-
ment of cortical neurons, glia cells, and RA-SH-SY5Y cells
with particular chemicals. Cell damage was quantified using
a tetrazolium salt colorimetric assay with 3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) as
described previously (Jantas et al. 2011). The absorbance of
each sample was measured at 570 nm in a 96-well plate-
reader (Multiscan, Labsystem). The data after subtraction of
blanks (absorbance of cells without MTT) were normalized
to the absorbance in the vehicle-treated cells (100 %) and
expressed as a percent of the control ± SEM established
from n = 5 wells per one experiment from three separate
experiments.
CalceinAM Staining of Viable Cells
In order to morphologically assess the changes in cell
viability in cortical neurons after treatment with Tian and
pro-apoptotic agents, we employed a cell-permeable
CalceinAM dye according the protocol described previ-
ously (Jantas and Lason 2009). The cells were evaluated
using an inverted fluorescence microscope (AxioObserver,
Carl Zeiss) with excitation wavelength 480 nm (green
fluorescence).
Identification of Pyknotic Nuclei by Hoechst 33342
Staining
In order to visually assess the changes in DNA structure
after cell treatment with pro-apoptotic factors and Tian in
cortical neurons and in RA-SH-SY5Y cells, Hoechst 33342
staining was applied as described previously (Jantas et al.
2011). That dye binds to double-stranded DNA and can be
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used to visualize highly compacted chromatin of frag-
mented pyknotic cell nuclei. Images were recorded using
an inverted fluorescence microscope (AxioObserver, Carl
Zeiss, Germany) with excitation wavelength 350 nm (blue
fluorescence). Uniformly stained nuclei were scored as
healthy, viable nuclei while those with condensed or
fragmented nuclei were identified as damaged one. The
number of cells with nuclei having normal and changed
(condensed or fragmented) morphology was counted in six
randomly chosen fields per a cover slip (150–200 cells);
two cover slips per condition from three separate experi-
ments were evaluated. The data were calculated as a per-
centage of damaged nuclei compared to the total number of
cells per one field and presented in histograms as the
mean ± SEM.
Identification of Apoptotic Nuclei by TUNEL Method
In order to determine DNA fragmentation in apoptotic
cells, the terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick-end labeling (TUNEL) technique was
applied using the In Situ Cell Death Detection Kit Fluo-
rescein (Roche Diagnostic) as described previously (Jantas
et al. 2011). The cortical neurons after Tian and St (24 h)
or Dox (36 h) exposure were washed with PBS, fixed with
4 % paraformaldehyde for 20 min and washed two times
with PBS. Subsequently, the cells were treated with 0.1 %
sodium citrate/0.1 % Triton X-100 for 2 min on ice, and
incubated with TUNEL reaction mixture for 60 min at
37 C. After washing, the TUNEL-labeled nuclei (green
points) were examined under excitation 470 nm using
Fig. 1 Tianeptine is neuroprotective in two models of neuronal
apoptosis in cultured primary neurons. a and b 7 DIV cortical neurons
were co-treated with tianeptine (T: 0.001–10 lM) and staurosporine
(St; 0.5 lM) for 24 h. Next, LDH level (a) was measured in the
culture medium from the treated cells and cell viability was estimated
in cells via MTT reduction method (b). c and d 7 DIV cortical
neurons were co-treated with tianeptine (T:0.01–10 lM) and doxo-
rubicin (Dox, 0.5 lM) for 48 h. Next, LDH level (c) was measured in
the culture medium from the treated cells and cell viability was
estimated in cells via MTT reduction method (d). The data from the
biochemical tests were normalized to the absorbance in the vehicle-
treated cells (100 %) and expressed as a percent of the con-
trol ± SEM established from n = 5 wells per one experiment from
three separate experiments. *p \ 0.05, **p \ 0.01, and ***p \ 0.001
versus vehicle-treated cells; #p \ 0.05 and ###p \ 0.001 versus St/
Dox-treated cells
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inverted fluorescence microscope (AxioObserver, Carl
Zeiss). Apoptotic nuclei were counted on recorded images
from six randomly chosen fields per a cover slip, two cover
slips per condition from three separate experiments and are
shown as the mean ± SEM of apoptotic nuclei per one
field.
Assessment of Caspase-3 Activity
The caspase-3 protease activity assay in the cortical neu-
ronal samples treated with St (0.5 lM) and Dox (0.5 lM)
for 14 and 24 h, respectively, was performed on 96-well
plates using colorimetric substrate preferentially cleaved
by caspase-3, AcDEVD-pNA (N-acetyl-asp-glu-val-asp
p-nitro-anilide) as described previously (Jantas-Skotniczna
et al. 2006). As a marker of assay specificity, the cell-
permeable caspase-3 inhibitor, AcDEVD-CHO (10 lM)
was added to St- or Dox-treated cells during cell treatment.
The amounts of p-nitroanilide cleaved by caspase-3 were
monitored continuously over 60 min with a plate-reader
(Multiscan, Labsystems) at 405 nm. Absorbance of blanks,
determined as no-enzyme control, has been subtracted from
each value. The data were normalized to the absorbance of
vehicle-treated cells (100 %) and expressed as percent of
absorbance ± SEM established from n = 5 wells per
experiment from three separate experiments.
The measurements of caspase-3 activity in RA-SH-
SY5Y cells were performed in the same lysis buffer as
described for primary neurons (Jantas-Skotniczna et al.
2006) but with some modifications. Cells were cultured in
six-well plate and after drug exposure (Tian and St or Dox
for 12 and 24 h, respectively), the culture medium was
removed, and cells were washed with cold PBS and stored
at -20 C until measurement (no more than 1 week). Next,
the cells were thawed on ice and lysed in 150 ll of ice-cold
Caspase Assay Buffer (50 mM HEPES, pH 7.4, 100 mM
Fig. 2 Tianeptine prevents the
reduction in the number of






neurons treated with tianeptine
(T: 0.1 lM) and St (0.5 lM) or
Dox (0.5 lM) for 24 and 36 h,
respectively. Photos were
recorded using a inverted
fluorescence AxioObserver
microscope (Carl Zeiss,
Germany) equipped with the
software Axiovision 3.1 at
excitation wavelengths of
470 nm (Alexa Fluor488)
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NaCl, 0.1 % CHAPS, 1 mM EDTA, 10 % glycerol, and
10 mM dithiothreitol) lysis buffer supplemented with
10 lg/ml of each leupeptin and pepstatin A for 15 min at
4 C. Next, the lysed cells were scraped and collected in
separate tubes and centrifuged at 16,0009g for 20 min at
4 C. The supernatants were used for determination of
caspase-3 activity by the usage of fluorometric substrate
Ac-DEVD-AMC (Promega), according to which the
amount of fluorochrome 7-amino-4-methyl coumarin
(AMC) is released from the substrate (Ac-DEVD-AMC)
upon cleavage by caspase-3-like enzymes. A yellow-green
fluorescence produced by free AMC is proportional to the
caspase-3 activity present in the sample. Cell lysates
(50 ll) were incubated with Ac-DEVD-AMC (50 lM) for
60 min at 37 C in the absence and presence of a specific
caspase-3 inhibitor (Ac-DEVD-CHO; 10 lM) and the
fluorescence was measured with a plate-reader (Infinite
M1000 PRO, Tecan, Switzerland) at 360 nm excitation and
460 nm emission wavelengths. The measurement was
performed in triplicates and mean RFU (relative fluores-
cence units) were calculated per mg of protein for each
experimental sample. The protein concentration in cell
lysates was determined with the bicinchoninic acid protein
assay kit (BCA1, Sigma). Data were presented as the mean
RFU/mg protein ± SEM established from n = 3 wells per
one experiment from three independent experiments.
Western Blotting Analysis
For Western blot analysis, cortical neurons were cultured in
six-well plates coated with poly-ornithine (0.05 mg/ml) and
after 7 DIV were treated for 6 and 18 h with Tian (0.1 and
10 lM) and St or Dox. For preparation of the whole cell
lysates, cells were washed with ice-cold PBS and harvested
and lysed with ice-cold RIPA buffer (150 mM NaCl, 1.0 %
IGEPAL CA-630, 0.5 % sodium deoxycholate, 0.1 % SDS,
50 mM Tris, pH 8.0) in the presence of a cocktail con-
taining protease inhibitors. For measurement of phosphor-
ylated forms of kinases (pERK), the lysis buffer was
enriched with heat-activated sodium orthovanadate and
phosphatase inhibitors (cocktail I and II). Cell lysates were
centrifuged at 20,0009g for 15 min at 4 C and the
supernatants were stored at -20 C until further use. Pro-
tein amounts were determined with the BCA method and
equal amount of proteins was denatured in a modified
Laemmli sample buffer (0.25 M Tris–HCl pH 6.8, 10 %
SDS, 40 % glycerol, 10 % 2-mercaptoethanol, 0.5 % bro-
mophenol blue) and boiled for 3 min. An equal amount of
protein from experimental groups was separated on 10 %
SDS–polyacrylamide gel and transferred onto a PVDF
membrane. Membranes were blocked for 1 h with 5 %
nonfat milk in TBS-T (Tris-buffered solution pH 7.5/
0.005 % Tween 20) and incubated overnight with primary
antibodies diluted at 1:500 (spectrin a II), 1:1000 (pERK)
and 1:2,000 (ERK2) in 1 % nonfat milk in TBS-T. The
amount of ERK2 was determined on the same membrane on
which the level of pERK and spectrin a II of were measured
by stripping and reprobing the membrane as described
previously (Jantas et al. 2011). The primary antibody
reaction was followed by 1 h incubation with relevant
secondary antibodies connected with horseradish peroxi-
dase. Immunocomplexes were detected using an enhanced
chemiluminescence detection system (Roche) and band
intensities were determined by densitometric analysis of
immunoblots (Fuji Film Las 4000). MultiGauge v.3 Soft-
ware was used for quantification of Western blot signals.
Table 1 The effects of antidepressants on St- and Dox-evoked cell





Control 100.00 ± 1.20 99.93 ± 3.08
Imi 10 89.53 ± 3.75 89.48 ± 3.24
Flu 10 85.96 ± 5.10* 68.24 ± 4.63***
Cit 10 92.15 ± 3.50 104.01 ± 4.17
Reb 10 100.38 ± 7.26 93.78 ± 4.07
Mirt 10 95.43 ± 3.77 117.09 ± 8.21
St/Dox 66.93 ± 1.20*** 63.66 ± 2.93***
?Imi 0.01 71.58 ± 5.07 67.02 ± 6.67
?Imi 0.1 78.68 ± 9.16 66.41 ± 5.31
?Imi 1 66.33 ± 3.71 72.16 ± 9.75
?Imi 10 62.61 ± 3.37 61.68 ± 3.81
?Flu 0.01 64.83 ± 6.03 78.74 ± 8.67
?Flu 0.1 64.58 ± 5.33 73.68 ± 6.55
?Flu 1 62.65 ± 4.42 65.13 ± 5.47
?Flu 10 46.57 ± 3.40# 35.28 ± 4.86###
?Cit 0.01 80.83 ± 8.15 69.47 ± 6.68
?Cit 0.1 78.89 ± 3.91 64.90 ± 7.15
?Cit 1 69.74 ± 3.46 70.10 ± 9.57
?Cit 10 65.09 ± 3.79 66.22 ± 2.92
?Reb 0.01 76.92 ± 6.58 70.77 ± 6.66
?Reb 0.1 72.67 ± 3.27 74.83 ± 7.07
?Reb 1 76.96 ± 5.34 64.80 ± 8.32
?Reb 10 67.07 ± 4.58 62.16 ± 2.65
?Mir 0.01 69.33 ± 1.87 76.39 ± 9.41
?Mir 0.1 62.79 ± 2.23 76.75 ± 8.72
?Mir 1 76.27 ± 5.42 70.97 ± 7.54
?Mir 10 63.99 ± 2.84 66.21 ± 2.23
MTT reduction assay was performed after treatment of cells with
antidepressants [0.01–10 lM: imipramine (Imi)], fluoxetine (Flu),
citalopram (Cit), reboxetine (Reb) and mirtazapine (Mir) and
staurosporine (St) or doxorubicin (Dox) (0.5 lM) for 24 and 36 h,
respectively. Data (n = 15) was normalized to vehicle-treated cells
(100 %) and expressed as a percent ± SEM * p \ 0.05 and
*** p \ 0.001 versus vehicle-treated cells; # p \ 0.05 and
### p \ 0.001 versus St/Dox-treated cells
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Data from duplicate determinations in three independent
experiments were normalized to ERK2 level in particular
samples and were shown as fold of control (mean ± SEM).
Data Analysis
Data after normalization were analyzed using the Statistica
software (StatSoft Inc., Tulsa, OK, USA). The analysis of
variance (one-way ANOVA) and post-hoc Tukey’s test for
multiple comparisons were used to show statistical signif-
icance with assumed p \ 0.05.
Results
Tianeptine Protects Neuronal Cells Against Cell Death
Induced by Pro-apoptotic Factors
Cortical neurons at 7 DIV are a suitable model for studies
of apoptotic processes evoked by pro-apoptotic factors
activating mitochondrial (St) and extracellular (Dox)
pathways of apoptosis as we reported previously (Jantas
et al. 2009; Jantas-Skotniczna et al. 2006). Tian when
given alone (0.01–10 lM) had no effect on cell viability of
cortical neurons measured by LDH release and MTT
reduction assays (not shown). However, Tian at low con-
centrations (0.01 and 0.1 lM) partially attenuated the St-
induced LDH release (by about 30 % of control value) and
increased cell viability by about 45–50 % (Fig. 1a, b). Tian
(0.1 lM) was also protective against Dox-evoked cell
death by reducing the changes in LDH release and MTT
reduction tests almost to the level found in vehicle-treated
cells (Fig. 1c, d). The neuroprotective effects of Tian found
in biochemical tests was confirmed by live staining of
cortical neurons with CalceinAM dye (Sup. Fig. 1) as well
as by anti-MAP-2 immunocytochemistry of fixed neurons
(Fig. 2).
The neuroprotective effects of Tian was also demon-
strated in RA-SH-SY5Y cells where this drug attenuated
the St (Tian 0.01 and 0.1 lM)- and Dox (Tian 0.1 lM)-
Fig. 3 Tianeptine attenuates staurosporine (St)- and doxorubicin
(Dox)-induced DNA fragmentation measured by Hoechst 33342
staining. (Left panel) Microphotographs from Hoechst 33342 staining
of cortical neurons treated with tianeptine (T: 0.001–1 lM) and St
(0.5 lM) for 24 h. a and b Histograms of number of cells with
fragmented nuclei after treatment of cortical neurons with tianeptine (T:
0.001–1 lM) and St (0.5 lM) or T (01 and 1 lM) and Dox (0.5 lM) for
24 or 36 h, respectively. Uniformly stained nuclei were scored as
healthy, viable nuclei while those with condensed or fragmented nuclei
were identified as damaged. The number of cells with nuclei having normal
and pyknotic morphology was counted in six randomly chosen fields per a
cover slip (150–200 cells); two cover slips per condition from three separate
experiments were evaluated. The data were calculated as a percentage of
pyknotic nuclei compared to the total number of cells per one field and
presented in histograms as the mean ± SEM ***p\0.001 versus vehicle-
treated cells; #p\0.05 and ###p\0.001 versus St/Dox-treated cells
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induced LDH release and increased cell viability by about
30–40 % (Sup. Fig. 2).
Lack of Neuroprotective Effects of Other ADs in the St
and Dox Models of Neuronal Apoptosis
In the next part of our study, we compared the neuropro-
tective effect of Tian with other ADs. During 24 h incu-
bation with Imi, Cit, Reb, Mirt at concentrations from 0.01
to 10 lM, we did not observe any detrimental effects of the
tested drugs given alone on cell viability (Table 1). Only
Flu at a concentration of 10 lM when given alone
significantly reduced (by about 15 %) cell viability and
also increased the cell death (by about 20 %) induced by St
and Dox (Table 1). However, we did not observe any
neuroprotective effects of Imi, Flu, Cit, Reb, Mirt
(0.01–10 lM) against St- or Dox-evoked cell damage
(Table 1).
In RA-SH-SY5Y cells from all tested ADs
(0.01–10 lM) only Flu (10 lM) significantly decreased
cell viability after 48 but not 24 h of treatment (Sup.
Table 1). Moreover, all tested ADs were ineffective in
preventing the cell death induced by St (0.5 lM for 24 h)
and Dox (1 lM for 48 h) (Sup. Table 1). For Imi (10 lM)
Fig. 4 Tianeptine decreases number of apoptotic nuclei estimated by
TUNEL assay. (Upper panel) Microphotographs from TUNEL
labeling of cortical neurons treated with tianeptine (T: 0.1 lM) and
staurosporine (St, 0.5 lM) or doxorubicin (Dox, 0.5 lM) for 24 and
36 h, respectively. (Bottom panel) Histograms of TUNEL-positive
nuclei after treatment of cortical neurons with tianeptine (T: 0.1 and
10 lM) and St (0.5 lM) or Dox (0.5 lM) for 24 or 36 h, respectively.
Apoptotic nuclei were counted on recorded images from six randomly
chosen fields per a cover slip, two cover slips per condition from three
separate experiments and are shown as the mean ± SEM of apoptotic
nuclei per one field. **p \ 0.01 and ***p \ 0.001 versus vehicle-
treated cells; ##p \ 0.01 and ###p \ 0.001 versus St/Dox-treated cells
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and Flu (10 lM) we showed a significant increase in cell
death induced by St or Dox by about 20–30 % and
30–40 %, respectively (Sup. Table 1).
Tianeptine Attenuated the St- and Dox-Evoked DNA
Fragmentation in Cortical Neurons and in RA-SH-
SY5Y Cells
Next, the neuroprotection mediated by Tian was evaluated
based on the level of DNA changes evoked by St and Dox.
Data from Hoechst 33342 staining showed that Tian
decreased the number of pyknotic nuclei induced by St and
Dox in cortical neurons (Fig. 3) and in RA-SH-SY5Y cells
(S. Fig. 3) at the same concentrations in which this drug
revealed neuroprotective action in the cell viability tests.
Since Hoechst 3342 staining does not clearly distinguish
the necrotic and apoptotic morphology of the nucleus, we
employed the TUNEL assay as a marker for apoptotic
DNA fragmentation. In cortical neurons, we showed the
attenuating effect of Tian (0.1 lM) on the number of
TUNEL-positive nuclei increased by St and Dox after 24
and 36 h of treatment, respectively (Fig. 4).
Tianeptine-Mediated Neuroprotection in Cortical
Neurons and in RA-SH-SY5Y Cells is Caspase-3-
Independent
In primary cortical neurons by using the biochemical
assay for assessment of caspase-3 activity with specific
colorimetric substrate Ac-DEVD-pNa, we showed that the
St- and Dox-induced caspase-3 activity was reduced by the
caspase-3 inhibitor, AcDEVD-CHO (10 lM) but not by
Tian (0.001–10 lM) after 14 and 24 h of treatment,
respectively (Table 2). The lack of influence of Tian on
caspase-3 activity was also confirmed indirectly by Western
Blot analysis of 120 kDa spectrin a II cleavage product
specifically cleaved by caspases after 18 h of treatment with
Tian (0.1 lM) and St and Dox (Fig. 5a, c). However, we
noticed some attenuation in the 120 kDa product after 6 h of
treatment with Tian (0.1 lM) and St when compared to cells
treated only with St (Fig. 5a, c).
In RA-SH-SY5Y cells, we did not find any significant
attenuation of St- and Dox-induced caspase-3 activity after
14 and 24 h of treatment, respectively, (S. Table 2) as was
confirmed by using biochemical assay with fluorescent
substrate Ac-DEVD-AMC.
We also analyzed the 145 kDa spectrin a II cleavage
product which is specifically cleaved by calpains, a Ca2?-
dependent proteases which could be involved in neuronal
cell death. We observed only slight increase (not signifi-
cant) in 145 kDa product after 18 h, but not 6 h of treatment
with St and Dox and that effect was not changed by Tian
(0.1 lM) (Fig. 5b). After 6 h of treatment, we observed the
attenuation by Tian (0.1 lM) in 145 kDa product when
compared to control cells (Fig. 5b).
The Neuroprotection Mediated by Tianeptine
in Neuronal Cells is Reduced by PI-3K/Akt
and MAPK/ERK1/2 Inhibitors
In order to verify the engagement of pro-survival PI3-K/
Akt and MAPK/ERK1/2 pathways in neuroprotection
mediated by Tian, we used pharmacological inhibitors. The
MAPK/ERK1/2 inhibitor, U0126 (10 lM) and the PI3-K/
Akt inhibitor, LY294002 (10 lM) attenuated the protection
mediated by Tian (0.1 lM) against St- and Dox-induced
cell damage in cortical neurons (Fig. 6a, b) as well as in
RA-SH-SY5Y cells (S. Fig. 4) at the same time having no
influence on the extent of cell damage induced by the used
cell death-inducing agents.
Performing Western blot analysis of cortical neurons
treated for 6 h with Tian we demonstrated that low con-
centration of Tian (0.1 lM) but not higher one (10 lM)
increased the pERK level when compared to vehicle-trea-
ted cells (Fig. 7).
Tianeptine-Evoked Neuroprotection was Inhibited
by the Necroptosis Inhibitor, Necrostatin-1
Since we excluded the participation of caspase-3 in neu-
roprotection mediated by Tian, in the next experiments we
Table 2 The effects of tianeptine on St- and Dox-induced caspase-3
activity in 7 DIV cortical neurons
Caspase-3 activity (% control)
Control 100.00 ± 6.27
Tian 10 99.20 ± 6.45
St 186.17 ± 5.95***
?AC-DEVD-CHO 73.52 ± 11.83###
?T 0.001 188.77 ± 3.70
?T 0.01 171.70 ± 4.65
?T 0.1 176.76 ± 5.11
?T 1 173.28 ± 3.23
?T 10 172.33 ± 3.40
Dox 174.19 ± 4.30***
?AC-DEVD-CHO 94.59 ± 14.29###
?T0.1 176.27 ± 3.46
?T 1 172.10 ± 5.52
?T 10 183.82 ± 3.62
The caspase-3 activity was measured after treatment of cortical cells
with tianeptine (T: 0.001–10 lM), AcDEVD-CHO (10 lM) and
staurosporine (St, 0.5 lM) or doxorubicin (Dox, 0.5 lM) for 14 (St)
and 24 (Dox) hr, respectively. Data was normalized to vehicle-treated
cells (100 %) and expressed as a percent ± SEM. *** p \ 0.001
versus vehicle-treated cells; ### p \ 0.001 versus St/Dox-treated cells
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checked the engagement of a caspase-3-independent form
of cell death, necroptosis, by the use of the inhibitor of this
programmed necrotic cell death, necrostatin-1 (Nec-1). We
showed that Nec-1 at specific concentrations served pro-
tection against St-(Nec-1 1 lM and 25 lM, but not 10 lM)
and Dox-(Nec-1 1 lM but not 10 and 25 lM) evoked cell
damage (Fig. 8a). Moreover, using a protective and non-
protective concentrations of Nec-1 (1 and 10 lM, respec-
tively) we demonstrated inhibition by this agent at both
concentrations of the protection mediated by Tian (0.1 lM)
against St- and Dox-evoked neuronal cell damage (Fig. 8b).
Predominant Neuroprotective Effect of Various
Antidepressants in Primary Glia Cells When Compared
to Neuronal Cultures
In glia cells, various tested ADs (Imi, Flu, Cit, Reb, Mirt,
Tian) in a wide concentration range (0.01–10 lM) when
given alone for 24 h had no influence on the basal LDH
release (not shown) but a significant increase in cell via-
bility was found for Mirt (10 lM) and Tian (1 and 10 lM))
as compared to the control cells (Fig. 9). Doxorubicin
(1 lM for 48 h) evoked about 50 % reduction in glia cell
viability as was measured by MTT reduction assay
(Fig. 10). Moreover, all tested ADs in various concen-
trations: Imi (0.1–10 lM), Flu (0.1–10 lL), Cit
(0.1–10 lM), Reb (10 lM), Mirt (0.1–10 lM), and Tian (1
and 10 lM) were protective against cell death induced by
Dox (1 lM) (Fig. 10).
Discussion
The results of the present study demonstrated that (1) from
the group of six tested ADs with differential mechanisms
of action (Imi, Flu, Cit, Reb, Mirt, Tian) only Tian was
found to be partially protective against St- and Dox-evoked
neuronal cell death, however, in glia cells all tested AD
Fig. 5 a Western blot analysis of spectrin a II cleavage products 145
and 120 kDa induced by calpains and caspase-3, respectively.
Cortical neurons were treated with tianeptine (Tian 0.1 lM) and
staurosporine (St, 0.5 lM) or doxorubicin (Dox, 0.5 lM) for 6 and
18 h. 145 and 120 kDa spectrin a II cleavage products and ERK2
protein levels were measured in whole cell lysates. b and c Histograms
showing the quantification of Western blots using MultiGauge v.3
Software. The band intensity of spectrin a II cleavage products (145
and 120 kDa) was normalized to ERK2 level (protein load control)
and calculated as fold change of control for each blot. Data from
duplicate determinations in three independent experiments were
shown as the mean ± SEM *p \ 0.05 and ***p \ 0.001 versus
vehicle-treated cells; #p \ 0.05 versus St-treated cells
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drugs provided significant protection against Dox-evoked
cell death, (2) neuroprotection mediated by Tian was
accompanied by the attenuation of apoptotic DNA frag-
mentation, although this effect was caspase-3-independent,
(3) protection evoked by Tian was reduced by inhibitors of
PI3-K/Akt and MAPK/ERK1/2 pathways, and (4) the
inhibitor of necroptosis, necrostatin-1 completely blocked
the Tian-mediated protection.
Our findings add to data on neuroprotective effects of
Tian and extend them to new models of apoptosis (St and
Dox), where Tian showed a significant protection. More-
over, in our study, the protective effect of Tian was
accompanied with attenuation of DNA fragmentation but
rather was not connected with changes in caspase-3 activity
as was measured on an in vitro assay with a standard
substrate.
Most previous reports showing neuroprotective action of
Tian in various in vivo and in vitro experimental settings
employed the chronic schedule of drug administration
(Lucassen et al. 2004; Plaisant et al. 2003). In our study, we
found protection after a single administration of Tian in a
model of neuronal injury not directly connected with glu-
tamate overactivity. This is in line with another report
showing protection after a single, but also after 5 day
administration of Tian (10 mg/kg i.p.) against brain lesions
induced by a combination of NMDA and IL-1b (Plaisant
et al. 2003). There are studies showing the anti-apoptotic
action of Tian (50 mg/kg p.o., 28 days) which was evi-
denced by attenuation of Tunel-positive cells in the tem-
poral cortex and hippocampal subgranular zone of animals
exposed to chronic psychosocial stress. However, that
in vivo study did not address the question of whether this
Fig. 6 Neuroprotective effects
of tianeptine (Tian) are blocked
by inhibitors of PI3-K/Akt and
MAPK/ERK1/2 pathways. Cell
viability after treatment of
cortical neurons with PI3-K/Akt
inhibitor, LY294002 (10 lM)
and MAPK/ERK1/2 inhibitor,
U0126 (10 lM) and Tian
(0.1 lM) and a staurosporine
(St, 0.5 lM) or b doxorubicin
(Dox, 0.5 lM) for 24 or 36 h,
respectively. ***p \ 0.001
versus vehicle-treated cells;
###p \ 0.001 versus St/Dox-
treated cells; &p \ 0.05 and
&&&p \ 0.001 versus St/
Dox ? Tian-treated cells
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effect was neuronal or glia specific (Lucassen et al. 2004).
In contrast to Tian, in our study we did not notice any
protection mediated by a single administration of other
tested ADs (Imi, Flu, Cit, Reb, Mirt) to primary neurons as
well as to neuronally differentiated human neuroblastoma
SH-SY5Y cells against St and Dox neurotoxicity. In con-
trast, previous studies demonstrated neuroprotective prop-
erties of various ADs in different models of cell death,
however, these effects were found after chronic adminis-
tration of drugs (reviewed by Drzyzga et al. 2009;
McKernan et al. 2009). There are also reports showing that
a single administration of some ADs could be protective in
various models of cellular injury although these agents
were not tested against St- and Dox-evoked cell death in
neuronal cells (Chiou et al. 2006; Chung et al. 2011; Nahon
et al. 2005; Zhang et al. 2012a). For example, Flu in
concentration of 3 lM was found to be neuroprotective
against LPS- and MPP ? (1-methyl-4-phenylpyridinium)-
evoked neurotoxicity in neuronal-glia co-cultures of mid-
brain neurons, whereas in concentration [10 lM attenu-
ated the St-evoked apoptosis of U937 cells (Nahon et al.
2005; Zhang et al. 2012a). However, in our study, we
observed cytotoxic effect of Flu (10 lM) after 24 and 36 h
of treatment in primary neurons when in RA-SH-SY5Y
cell-damaging effect of Flu (10 lM) was noticed only after
48 but not 24 h of treatment (Table 1; Sup. Table 1). Using
higher concentration of Flu (50 lM), we observed highly
toxic effect of this drug in both, primary neurons as well in
RA-SH-SY5Y cells (data not shown). Moreover, in our
study Flu (10 lM) also increased the cell death induced by
St and Dox in primary neurons as well in RA-SH-SY5Y
cells, whereas Imi (10 lM) elevated the cell death evoked
by St and Dox only in RA-SH-SY5Y cells. Thus, the above
data add to the reports demonstrating pro-apoptotic action
of higher concentrations of some ADs when given alone or
in combination with some chemotherapeutics which seems
to be dependent on the type of AD drug, the used cells as
well as on cell culture conditions (Abdel-Razaq et al. 2011;
Argov et al. 2009; Drzyzga et al. 2009; Levkovitz et al.
2005).
In contrast to neuronal cells, in glia cells we demon-
strated a protective effect of all tested ADs against cell
death induced by Dox. This observation suggests that the
previously described neuroprotective effects of various
ADs in the in vivo situation could be partly due a result of
their influence on glia cells (Drzyzga et al. 2009; Martin
et al. 2013; McKernan et al. 2009). The more detailed
studies in neuronal-glia cultures showed that the regulating
effect of this drug on the pro-inflammatory factors induced
by toxin exposure was the key step in the neuroprotective
effects of Tian or Flu (Chung et al. 2011; Plaisant et al.
2003; Zhang et al. 2012a). It should be underlined that in
our study the protective effect of Tian in neuronal and glia
cells differed according to the concentrations used, namely
Tian at low concentrations (0.01 an 0.1 lM) was effective
in neurons while at higher doses (1 and 10 lM) it was
protective in glia cells, which suggests the involvement of
different mechanisms. Regarding the protective effect of
Mirt and Tian in glia cells against Dox-evoked cell dam-
age, it cannot be excluded that this effect was due to their
influence on cell proliferation since these agents when
given alone increased the viability of glia cells (Fig. 7).
Further evaluation of the mechanisms engaged in ADs-
mediated neuroprotection against Dox toxicity would be
very important from the clinical point of view since glia
cell damage occurs during chemotherapy and concomi-
tantly with neuronal cell damage participate in neurocog-
nitive impairments observed in patients after long-term
chemotherapy (Bigotte and Olsson 1983; Moriuchi et al.
1996; O’Farrell et al. 2013; Tarasenko et al. 2012).
Regarding the protective effects of Tian in glia cells, it has
been shown that Tian (10–100 lM) attenuated the gp120-
evoked cell death in glia cells and this effect was connected
with attenuation of caspase-3 activity, DNA fragmentation
and the influence of this drug on the expression and activity
of glutamine synthase (GS), transcription factor NFjB, and
nitric oxide system (NO, cNOS, iNOS) (Janda et al. 2011).
Studying the possible mechanism of neuroprotective
action of Tian in cortical neurons and RA-SH-SY5Y cells,
we excluded the participation of caspase-3 on the basis of
performed biochemical assay using caspase-3 specific
substrate. We confirmed these results by second method,
analysis of 120 KDa cleavage product of spectrin a II
Fig. 7 (Upper panel) Representative blots showing the phosphory-
lated (pERK) and total form of ERK 1/2 after 6 h of treatment with
Tian (0.1 and 10 lM). Histograms show the quantification of Western
blots using MultiGauge v.3 Software. The band intensity of pERK
was normalized to ERK 1/2 level and calculated as fold change of
control for each blot. Data from duplicate determinations in three
independent experiments were shown as the mean ± SEM
***p \ 0.001 versus vehicle-treated cells
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induced by caspases, where we did not observe any attenu-
ation of St- or Dox-evoked increase in this product after 18 h
of treatment with Tian and pro-apoptotic factors. However,
after 6 h of treatment with drugs, we noticed a significant
reduction in 120 kDa product in St ? Tian group when
compared to cell treated only with St. These data suggests
that Tian could interfere with the caspase-3 activity tran-
siently which could only delay but not stop the cell death
progression induced by St or Dox. In fact, inhibitor of cas-
pase-3 (Ac-DEVD-CHO) was able only partially (about
25 % decrease in LDH level) diminish the cell death induced
by St and Dox in cortical neurons as we reported in our
previous studies (Leskiewicz et al. 2008; Jantas and Lason
2009). The data obtained in this study suggests that some
caspase-3-independent mechanisms could be engaged in
Tian neuroprotection. Exploring further the caspase-3-
independent targets for the neuroprotective action of Tian,
we tested the engagement of necroptosis, a programmed
necrotic cell death pathway (Christofferson and Yuan 2010).
It is well known that the same harmful stimulus can induce
both apoptosis and necroptosis in in vitro and in vivo con-
ditions (Ji et al. 2011; Sˇimenc and Lipnik-Sˇtangelj 2012;
Wang et al. 2012). Necroptosis was firstly discovered in
immunology and oncology field, however, recently it is also
very often described in relation to neurodegeneration, e.g., in
the retinal ischemia–reperfusion injury model, neonatal
ischemia, and glutamate toxicity (Chavez-Valdez et al.
2012; Degterev et al. 2005, 2008; Northington et al. 2011;
Rosenbaum et al. 2010; Wang et al. 2012; Xu et al. 2007;
Zhang et al. 2013). The participation of necroptosis was also
reported to be involved in St-evoked cell damage in glia cells
and U937 cells as well as in cisplatin-induced kidney injury
(Dunai et al. 2012; Sˇimenc and Lipnik-Sˇtangelj 2012; Tris-
ta˜o et al. 2012). In our study, we showed that the inhibitor of
Fig. 8 Necrostatin-1 (Nec-1) is
neuroprotective against St- and
Dox-evoked cell damage as well
diminishes the protection
mediated by Tian. a Cell
viability after treatment of
cortical neurons with inhibitor
of necroptosis, Nec-1 (1-
25 lM) and staurosporine (St,
0.5 lM) and doxorubicin (Dox,
0.5 lM) for 24 and 36 h,
respectively. b Cell viability
after treatment of cortical
neurons with inhibitor of
necroptosis, Nec-1 (1 and
10 lM) and Tian (0.1 lM) and
staurosporine (St, 0.5 lM) and
doxorubicin (Dox, 0.5 lM) for
24 and 36 h, respectively. Data
were normalized to the
absorbance in the vehicle-
treated cells (100 %) and
expressed as a percent of the
control ± SEM established
from n = 5 wells per one
experiment from four separate
experiments. ***p \ 0.001
versus vehicle-treated cells;
#p \ 0.05 and ###p \ 0.001
versus St/Dox- treated cells;
&p \ 0.05 and &&&p \ 0.001
versus St/Dox ? Tian-treated
cells
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necroptosis, necrostatin-1 (Nec-1) was able to attenuate the
extent of cell damage evoked by St and Dox, however the
most significant effect was achieved at its low concentration
(1 lM) and this effect was comparable with protection
mediated by Tian (about 30 %). Moreover, in case of St
toxicity, we observed protective effect of Nec-1 25 lM, but
not 10 lM. These observations suggest that possible dif-
ferent mechanisms could be involved in Nec-1 mediated
neuroprotection al least in St model of neuronal cell death.
Interestingly, in our study the protective as well non-pro-
tective concentrations of Nec-1 (1 and 10 lM, respectively)
inhibited the protection mediated by Tian against St- and
Dox-induced cell damage. However, the mechanisms
responsible for observed by us effects with Nec-1 needs
further investigations starting from the study of activity of
receptor interacting protei kinase 1 (RIP1) which is a main
player in induction of necroptotic pathway (Christofferson
and Yuan 2010; Degterev et al. 2005, 2008). In fact, the
involvement of this type of programmed cell death in neu-
rodegeneration and neuroprotection field it still at its early
years of investigation and there are plenty of unresolved
questions, especially RIP1 downstream executioners has not
been identified yet (Christofferson and Yuan 2010). Never-
theless, it has been shown that necroptosis could be involved
Fig. 9 Effect of all tested antidepressants (ADs) when given alone on
cell viability of glia cultures. 4-weeks old glia cells were treated with
ADs: imipramine (Imi), fluoxetine (Flu), citalopram (Cit), reboxetine
(Reb), mirtazapine (Mirt), and tianeptine (Tian) at concentrations
from 0.01 to 10 lM. Cell viability was estimated via MTT reduction
method and data were normalized to the absorbance in the vehicle-
treated cells (100 %) and expressed as a percent of the con-
trol ± SEM established from n = 5 wells per one experiment from
three separate experiments. *p \ 0.05 and ***p \ 0.01 versus
vehicle-treated cells
Fig. 10 All tested
antidepressants (ADs) are
protective against doxorubicin
(Dox)-evoked cell damage in
glia cells. 4-weeks old glia cells




(Mirt), and tianeptine (Tian) at
concentrations from 0.01 to
10 lM and doxorubicin (Dox,
1 lM for 48 h). Cell viability
was estimated via MTT
reduction method and data were
normalized to the absorbance in
the vehicle-treated cells
(100 %) and expressed as a
percent of the control ± SEM
established from n = 5 wells
per one experiment from three
separate experiments.
***p \ 0.001 versus vehicle-
treated cells; #p \ 0.05,
##p \ 0.01, and ###p \ 0.001
versus Dox-treated cells
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in protection mediated by curcumin against iron induced
neurotoxicity in primary cortical neurons (Dai et al. 2013).
The last aspect of our study was demonstration that the
Tian-mediated protection against St and Dox toxicity in
cortical neurons and in RA-SH-SY5Y cells was attenuated
by inhibitors of MAPK/ERK1/2 and PI3K/Akt pro-survival
pathways. This suggests the existence of a common
upstream step which possibly is regulated by Tian and
consequently leads to the activation of PI3-K/Akt and
MAPK/ERK1/2. The involvement of the above pro-sur-
vival kinase pathways in the protective effects of various
potentially neuroprotective drugs was firmly evidenced
(Gabryel et al. 2002; Hetman and Gozdz 2004; Sawe et al.
2008; Zhu et al. 2004). In relation to ADs, it has been
shown that Flu could induce MAPK/ERK1/2 and PI3-K/
Akt pathways in astrocytes whereas moclobemide (50 lM)
increased pERK level in neural stem cells (McKernan et al.
2009). It is highly possible that the activation of pro-sur-
vival intracellular pathways by ADs could be the effect of
action of neurotrophic factors (e.g., BDNF, GDNF) the
increase of which has been reported in some forebrain
structures after acute and chronic ADs treatment including
Tian (Chu et al. 2010; Della et al. 2012b, 2013; Jang et al.
2009; McKernan et al. 2009; Saarelainen et al. 2003; Sa-
iranen et al. 2005, 2007). In our study, we confirmed the
participation of activation of ERK 1/2 pathway in neuro-
protective effects of Tian by showing the increase in pERK
protein level after 6 h of treatment with low (0.1 lM) but
not higher (10 lM) concentration of Tian. These data
strengthen the hypothesis proposed by Xu et al. (2003),
who suggested that some ADs affect pro-survival pathways
only in lower concentrations, not in higher one. These
authors demonstrated in in vivo situation that the neuro-
protective effects of ADs may be limited to a dose that,
when exceeded, provides no neuroprotection or even exerts
cytotoxic effect. This was shown in study with chronic
(21 days) amitriptyline or venlafaxine i.p. administration to
male Sprague–Dawley rats where low dose (5 mg/kg), but
not higher (10 mg/kg) of both drugs increased BDNF in
hippocampus (Xu et al. 2003). Interestingly, in our very
recent paper we found that various ADs, including Tian,
only in lower concentrations but not in higher one pre-
vented the anti-proliferative effect of dexamethasone in
human neuroblastoma SH-SY5Y cells and this effect was
connected with their influence on ERK1/2 activity (Les-
kiewicz et al. 2013).
Summing up, we demonstrated that from the group of
the tested ADs with differential mechanisms of action (Imi,
Flu, Cit, Reb, Mirt, Tian) only Tian was found to be pro-
tective in vitro against St- and Dox-evoked neuronal cell
death. However, in glia cells all tested ADs were protective
against Dox-evoked cell death. Next, we showed that
neuroprotection mediated by Tian was accompanied by the
attenuation of apoptotic DNA fragmentation, although this
effect was rather caspase-3-independent. Finally, the pro-
tection mediated by Tian was attenuated by inhibitors of
PI3-K/Akt and MAPK/ERK1/2 pathways as well as by the
necroptosis inhibitor, necrostatin-1 which points to
involvement of these processes in the molecular mecha-
nism of neuroprotective action of Tian.
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